SIC
SJS Investment Consulting’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37K | Sell |
83
-12
| -13% | -$5.34K | 0.01% | 210 |
|
|
2025
Q1 | $46.1K | Buy |
95
+30
| +46% | +$14.5K | 0.01% | 200 |
|
|
2024
Q4 | $26.2K | Sell |
65
-5
| -7% | -$2.01K | ﹤0.01% | 252 |
|
|
2024
Q3 | $32.6K | Hold |
70
| – | – | 0.01% | 233 |
|
|
2024
Q2 | $32.8K | Hold |
70
| – | – | 0.01% | 216 |
|
|
2024
Q1 | $29.3K | Hold |
70
| – | – | 0.01% | 240 |
|
|
2023
Q4 | $28.5K | Sell |
70
-84
| -55% | -$34.2K | 0.01% | 207 |
|
|
2023
Q3 | $53.6K | Buy |
154
+56
| +57% | +$19.5K | 0.01% | 153 |
|
|
2023
Q2 | $34.5K | Buy |
98
+2
| +2% | +$704 | 0.01% | 178 |
|
|
2023
Q1 | $30.2K | Sell |
96
-6
| -6% | -$1.89K | 0.01% | 187 |
|
|
2022
Q4 | $29.5K | Buy |
102
+39
| +62% | +$11.3K | 0.01% | 193 |
|
|
2022
Q3 | $18K | Buy |
+63
| New | +$18K | 0.01% | 250 |
|
|
2022
Q1 | $3K | Buy |
+8
| New | +$3K | ﹤0.01% | 493 |
|